Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Efruxifermin drives multidimensional histologic improvement in compensated cirrhosis: An AI-based analysis from the SYMMETRY randomized controlled trial
Authors:
Mazen Noureddin1; Jӧrn Schattenberg2; Vlad Ratziu3; Ylaine Gerardin4; Alyson R. Warr4; Jacqueline Brosnan-Cashman4; Doreen Chan5; Erik J. Tillman5; Reshma Shringarpure5; Mary E. Rinella6